Neuraxis to participate in the lytham partners spring 2024 investor conference on may 30, 2024

Carmel, ind., may 21, 2024 (globe newswire) -- neuraxis, inc. (“neuraxis,” or the “company”) (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will participate in a webcasted presentation and host one-on-one meetings with investors at the lytham partners spring 2024 investor conference, taking place virtually on thursday, may 30, 2024.
NRXS Ratings Summary
NRXS Quant Ranking